ScreenIn3D develops a unique microfluidic screening platform for precision medicine.
ScreenIn3D has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
ScreenIn3D's investors include University of Strathclyde, Scottish Enterprise, TRICAPITAL, Gabriel Investments, Nidobirds Ventures.
ScreenIn3D is headquartered in Glasgow, United Kingdom.
ScreenIn3D develops a unique microfluidic screening platform for precision medicine.
ScreenIn3D is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ScreenIn3D — Funding & Investors." VCBacked, June 12, 2025, https://www.vcbacked.co/company/screenin3d. Accessed August 14, 2026.
VCBacked. (2025). ScreenIn3D — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/screenin3d
{{cite web |title=ScreenIn3D — Funding & Investors |url=https://www.vcbacked.co/company/screenin3d |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated